Neuroprotective effects of creatine.

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Creatine is known for its role in cellular energy metabolism.
• Existing literature suggests creatine possesses neuroprotective properties.
• Neurodegenerative diseases are characterized by progressive neuronal dysfunction and loss.

Purpose of the Study:

• To investigate the in vivo efficacy of creatine as a neuroprotective agent.
• To evaluate creatine's effects in transgenic mouse models of neurodegenerative diseases.
• To assess the combined neuroprotective effects of creatine and coenzyme Q10.

Main Methods:

• In vivo studies using N-methyl-D-aspartate, malonate, 3-nitropropionic acid (3-NP), and MPTP models.
• Evaluation in transgenic mouse models for amyotrophic lateral sclerosis (ALS) and Huntington's disease (HD).
• Assessment of creatine combined with coenzyme Q10 (CoQ10) in MPTP and 3-NP toxicity models.

Main Results:

• Creatine protected against excitotoxic lesions and toxins like malonate and 3-NP.
• Dose-dependent neuroprotection was observed against MPTP toxicity, preserving dopamine levels.
• In ALS and HD models, creatine improved survival, motor function, and reduced neuronal loss or atrophy.
• Combination therapy with CoQ10 showed additive neuroprotective effects and reduced alpha-synuclein aggregates.

Conclusions:

• Creatine exhibits significant neuroprotective effects in various in vivo models.
• It shows promise for treating neurodegenerative conditions like ALS, HD, and Parkinson's disease.
• Clinical trials are underway to confirm creatine's therapeutic benefits in human patients.